These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3878821)

  • 1. [Individual tolerance of drugs for rheumatic diseases].
    Miehle W
    Fortschr Med; 1985 Dec; 103(47-48):1102-4. PubMed ID: 3878821
    [No Abstract]   [Full Text] [Related]  

  • 2. Rare toxicity with nonsteroidal antiinflammatory drugs.
    Kraag GR
    J Rheumatol; 1985 Feb; 12(1):1-3. PubMed ID: 3872362
    [No Abstract]   [Full Text] [Related]  

  • 3. Activity and tolerance of oxamethacin.
    Verhaegen H
    Methods Find Exp Clin Pharmacol; 1982; 4(8):617-23. PubMed ID: 6763119
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic efficacy of a new antirheumatic agent with optimal gastrointestinal tolerance: 2-phenyl-4,p-chlorophenyl-thiazol-5-ilacetic acid (Fentiazac)].
    Gorini M; Chizzi A; Dal Ri P; De Caro L
    Reumatismo; 1976; 28(1):15-29. PubMed ID: 1088315
    [No Abstract]   [Full Text] [Related]  

  • 5. [Non-steroidal anti-inflammatory drugs in the treatment of rheumatic diseases].
    Olhagen B
    Nord Med; 1985; 100(1):11-3. PubMed ID: 3875835
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug therapy of rheumatic diseases during pregnancy.
    Soscia PN; Zurier RB
    Bull Rheum Dis; 1992; 41(2):1-3. PubMed ID: 1600444
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy and compatibility of bumadizone-Ca in rheumatoid diseases. A comparison with oxyphenbutazone].
    Widhammer M; Frenger W
    Arzneimittelforschung; 1973 Dec; 23(12):1813-6. PubMed ID: 4544614
    [No Abstract]   [Full Text] [Related]  

  • 8. Nonsteroidal anti-inflammatory drugs (NSAID): use and misuse.
    Furst DE
    J Iowa Med Soc; 1983 May; 73(5):186-91. PubMed ID: 6602854
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dangers in the use of various rheumatic drugs].
    Wawrzyńska-Pagowska J
    Pol Tyg Lek; 1969 May; 24(21):809-12. PubMed ID: 4308591
    [No Abstract]   [Full Text] [Related]  

  • 10. [Liver tolerance of niflumic acid during treatment of degenerative rheumatic disease].
    Franke G
    Ther Ggw; 1972 Dec; 111(12):1780 passim. PubMed ID: 4569031
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experiences with an anti-rheumatis drug Soripal].
    Gross D
    Schweiz Rundsch Med Prax; 1971 Oct; 60(40):1334-6. PubMed ID: 5315454
    [No Abstract]   [Full Text] [Related]  

  • 12. [The pharmacotherapy of rheumatoid diseases (2): the action of anti-rheumatic drugs on the synthesis of certain connective tissue components].
    Boström H
    Lakartidningen; 1969 Oct; 66():Suppl 3:53-5. PubMed ID: 4245944
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-rheumatic drugs or the drug therapy of rheumatic diseases].
    Gross D
    Ther Umsch; 1972 Aug; 29(8):461. PubMed ID: 4538296
    [No Abstract]   [Full Text] [Related]  

  • 14. [2-(4-Isobutylphenyl)-propionic acid in the treatment of rheumatic diseases: clinical effects and tolerance].
    Viara M
    Minerva Med; 1973 Jun; 64(47):2513-4. PubMed ID: 4579843
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of anti-inflammatory drugs in children].
    Hoppu K; Korpela R
    Duodecim; 1994; 110(6):607-14. PubMed ID: 7555861
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug reactions. XII. Cutaneous reactions to anti-rheumatic drugs.
    Almeyda J; Baker H
    Br J Dermatol; 1970 Dec; 83(6):707-11. PubMed ID: 4250591
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical studies on the use of pyrazanone with special regard to its tolerance].
    D'Ingianna E
    Reumatismo; 1974; 26(3):196-7. PubMed ID: 4620107
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antirheumatic drugs in general practice].
    Ott VR
    Dtsch Med J; 1972 Dec; 23(12):696-701. PubMed ID: 4540583
    [No Abstract]   [Full Text] [Related]  

  • 19. [Findings on the causes and mechanisms in the development of undesirable effects of non-steroidal anti-rheumatic agents and their incidence in controlled clinical trials].
    Pavelka K; Vojtísek D; Kañkova D; Perlík F; Pelísková Z
    Fysiatr Revmatol Vestn; 1982 Jan; 60(1):1-10. PubMed ID: 7040188
    [No Abstract]   [Full Text] [Related]  

  • 20. [Multicenter study of Felden 20 suppositories in 3887 patients].
    von Criegern T
    Med Welt; 1983 Nov; 34(45):1290-3. PubMed ID: 6358773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.